(PEX) ProShares Global Listed - Ratings and Ratios
Private, Equity, Investments
Description: PEX ProShares Global Listed
The ProShares Global Listed Private Equity ETF (BATS:PEX) is an investment vehicle that seeks to replicate the performance of the most actively traded listed private equity companies, primarily those pursuing direct private equity investment strategies. By investing in a combination of financial instruments, the fund aims to provide exposure to this niche segment of the market.
The underlying index tracks the performance of listed private equity companies, providing a benchmark for the funds investments. With at least 80% of its assets invested in the components of the index or similar instruments, the fund is heavily aligned with the indexs performance. As a non-diversified fund, PEX is more concentrated in its holdings, which can result in higher volatility.
Analyzing the technical data, we observe that PEX is currently trading at $27.18, slightly above its 20-day simple moving average (SMA) of $27.12, indicating a potential bullish trend. The 50-day SMA is at $26.74, and the 200-day SMA is at $27.06, suggesting a longer-term uptrend. The average true range (ATR) is $0.35, or 1.29%, indicating moderate volatility. Given the current price is near the 200-day SMA and above the 50-day SMA, we can expect a potential continuation of the uptrend, with a target price near the 52-week high of $29.08.
Considering the fundamental data, the Assets Under Management (AUM) for PEX stand at $13.57M USD. While this is a relatively small AUM, it does not necessarily indicate a lack of investor interest. The funds niche focus on listed private equity companies may attract a dedicated investor base. Looking ahead, if the private equity market continues to grow, and listed private equity companies maintain their momentum, PEX could potentially benefit, driving its price higher.
Combining technical and fundamental insights, a forecast for PEX suggests a potential increase towards the 52-week high of $29.08, driven by the continuation of the uptrend and the growth prospects in the private equity market. However, investors should be cautious of the moderate volatility and the potential risks associated with a non-diversified fund.
Additional Sources for PEX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PEX ETF Overview
Market Cap in USD | 13m |
Category | Miscellaneous Sector |
TER | 0.81% |
IPO / Inception | 2013-02-26 |
PEX ETF Ratings
Growth Rating | 57.4 |
Fundamental | - |
Dividend Rating | 72.7 |
Rel. Strength | -4.7 |
Analysts | - |
Fair Price Momentum | 29.72 USD |
Fair Price DCF | - |
PEX Dividends
Dividend Yield 12m | 12.41% |
Yield on Cost 5y | 21.71% |
Annual Growth 5y | 17.30% |
Payout Consistency | 60.0% |
Payout Ratio | % |
PEX Growth Ratios
Growth Correlation 3m | 94.8% |
Growth Correlation 12m | 56.6% |
Growth Correlation 5y | 57.4% |
CAGR 5y | 12.59% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 0.77 |
Alpha | -2.41 |
Beta | 0.716 |
Volatility | 10.39% |
Current Volume | 1.5k |
Average Volume 20d | 2.8k |
As of July 06, 2025, the stock is trading at USD 28.19 with a total of 1,500 shares traded.
Over the past week, the price has changed by +1.88%, over one month by +4.94%, over three months by +16.24% and over the past year by +8.79%.
Partly, yes. Based on ValueRay´s Analyses, ProShares Global Listed (BATS:PEX) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.43 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PEX is around 29.72 USD . This means that PEX is currently overvalued and has a potential downside of 5.43%.
ProShares Global Listed has no consensus analysts rating.
According to our own proprietary Forecast Model, PEX ProShares Global Listed will be worth about 34.1 in July 2026. The stock is currently trading at 28.19. This means that the stock has a potential upside of +20.82%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 34.1 | 20.8% |